Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
WEUSKOP5410: Observational Study in ENABLE Clinical Trials
This study is ongoing, but not recruiting participants.
Study NCT01458080 Information provided by GlaxoSmithKline
First Received on July 7, 2011. Last Updated on November 28, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Phlebitis
Hepatitis C
Unstable Angina
Deep Vein Thrombosis
Ischemic Stroke
Pulmonary Embolism
Ischaemic Attack, Transient
Thrombocytopenia
Thrombophlebitis
Myocardial Infarction
Portal Vein Thrombosis
Additional conditions recognized in this trial
Angina, Unstable
Embolism
Hepatitis
Hepatitis A
Infarction
Ischemia
Ischemic Attack, Transient
Stroke
Thromboembolism
Thrombosis
Venous Thrombosis
More general conditions related to this trial
Angina Pectoris
Blood Platelet Disorders
Brain Diseases
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Chest Pain
Digestive System Diseases
Embolism and Thrombosis
Enterovirus Infections
Flaviviridae Infections
Heart Diseases
Hematologic Diseases
Hepatitis, Viral, Human
Liver Diseases
Lung Diseases
Myocardial Ischemia
Necrosis
Nervous System Diseases
Pain
Pathologic Processes
Peripheral Vascular Diseases
Picornaviridae Infections
Respiratory Tract Diseases
RNA Virus Infections
Signs and Symptoms
Vascular Diseases
Vasculitis
Virus Diseases
Interventions listed in this trial
eltrombopag
Sponsors listed in this trial
GlaxoSmithKline
Back to top of Main Content
